sulfisoxazole has been researched along with Cardiac Hypertrophy in 1 studies
Sulfisoxazole: A short-acting sulfonamide antibacterial with activity against a wide range of gram- negative and gram-positive organisms.
sulfisoxazole : A sulfonamide antibacterial with an oxazole substituent. It has antibiotic activity against a wide range of gram-negative and gram-positive organisms.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
O'Connell, B | 1 |
1 other study available for sulfisoxazole and Cardiac Hypertrophy
Article | Year |
---|---|
Pericarditis following meningococcic meningitis.
Topics: Ampicillin; Anemia; Cardiomegaly; Carrier State; Cerebrospinal Fluid; Dehydration; Drainage; Electro | 1973 |